“…Similarly, acetyl-CoA carboxylase (ACC) PKA activator 30 min 20 μM [ 76] activation is a common finding across all cell types following AICAR treatment (C2C12, [51,76]; L6, [43,60,98]; human [36]). Other exercise-like changes reported following AICAR treatment include increased GLUT4 protein content [91,107], glucose uptake or oxidation [17,66,77,98,107], fatty acid uptake or oxidation [60,66,82,98], insulin responsiveness [10,124], GLUT4 translocation [43,107], mitochondrial content [22] and IL-6 secretion [110]. However, in contrast to some of these above-described findings, other studies demonstrate a lack of effect of AICAR upon PGC-1α mRNA expression [6,110], pyruvate dehydrogenase kinase 4 (PDK4) mRNA expression [6,64], FNDC5 (gene that encodes for irisin) mRNA expression [110], as well as lack of effect upon protein kinase B (Akt) protein content [56] and activation [31,43], as well as Akt substrate 160 (AS160) activation [31,43].…”